Laboratory-based, 2-year surveillance of pediatric parapneumonic pneumococcal empyema following heptavalent pneumococcal conjugate vaccine universal vaccination in Madrid.

@article{Picazo2011Laboratorybased2S,
  title={Laboratory-based, 2-year surveillance of pediatric parapneumonic pneumococcal empyema following heptavalent pneumococcal conjugate vaccine universal vaccination in Madrid.},
  author={Juan Jos{\'e} Picazo and J{\'e}sus Ruiz-Contreras and Juan Casado-Flores and Sagrario Negreira and Fernando del Castillo and Teresa Hern{\'a}ndez-Sampelayo and Mercedes Bueno and Cristina Calvo and Esther R{\'i}os and Cristina M{\'e}ndez},
  journal={The Pediatric infectious disease journal},
  year={2011},
  volume={30 6},
  pages={471-4}
}
BACKGROUND In October 2006, the heptavalent pneumococcal conjugate vaccine was included in the Madrid vaccination calendar, warranting serotype (St) surveillances in pneumococcal pediatric parapneumonic empyema (PPE). METHODS A prospective 2-year (May 2007-April 2009) laboratory-confirmed PPE surveillance was performed in 22 hospitals. All isolates (for serotyping) and culture-negative pleural fluids were sent to the reference laboratory for polymerase chain reaction (PCR) analysis. RESULTS… CONTINUE READING